Send us Feedback

Flamel Technologies S.A. (FLML)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Flamel Tech Receives FDA Approval for Bloxiverz
Benzinga  Jun 3  Comment 
Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for Bloxiverz(TM) (neostigmine methylsulfate), a drug used intravenously in the operating...
Flamel (FLMML) Bloxiverz NDA Approved by U.S. FDA
StreetInsider.com  Jun 3  Comment 
Flamel Technologies (FLML) Tops Q1 Loss Views
StreetInsider.com  May 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Flamel+Technologies+%28FLML%29+Tops+Q1+Loss+Views/8310723.html for the full story.
Flamel Technologies (FLML) Tops Q4 EPS by 11c
StreetInsider.com  Feb 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Flamel+Technologies+%28FLML%29+Tops+Q4+EPS+by+11c/8141303.html for the full story.
Flamel Technologies (FLML) Misses Q3 EPS by 7c
StreetInsider.com  Nov 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Flamel+Technologies+%28FLML%29+Misses+Q3+EPS+by+7c/7843033.html for the full story.
Flamel Tech Gets PDUFA Date of May 31, 2013 for New Drug
Benzinga  Oct 18  Comment 
Flamel Technologies SA (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for an undisclosed hospital-based product. Flamel has received a Prescription Drug User...
Flamel Technologies (FLML) Posts Q2 Loss of 5c/Share
StreetInsider.com  Jul 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Flamel+Technologies+%28FLML%29+Posts+Q2+Loss+of+5cShare/7604769.html for the full story.
Flamel Technologies Announces Projected Release Date of Second Quarter 2012 Results and Conference Call
Marketwire  Jul 23  Comment 
LYON, FRANCE -- (Marketwire) -- 07/23/12 -- Flamel Technologies (NASDAQ: FLML) expects to release certain financial results for the second quarter of 2012, on Thursday, July 26th, before the market open. A conference call to discuss these results has
Flamel Technologies Medusa(R)-Formulated Interferon-Alpha Demonstrates Favorable Antiviral Activity and Safety in a Phase 2 Clinical Study
Marketwire  Jun 25  Comment 
LYON, FRANCE -- (Marketwire) -- 06/25/12 -- Flamel Technologies (NASDAQ: FLML) today announced that its Medusa-formulated interferon-alpha ("IFN a-2b XL") was featured in a lecture and an oral presentation on June 25 at the 14th International
Flamel Technologies Announces Results of Annual Meeting and Election of Stephen H. Willard Chairman
Marketwire  Jun 25  Comment 
LYON, FRANCE -- (Marketwire) -- 06/25/12 -- Flamel Technologies S.A. (NASDAQ: FLML) today announced voting results from the Company's annual ordinary and extraordinary meeting held on June 22, 2012. Approximately 98 percent of outstanding shares were
Flamel Technologies (FLML) Lower Following Wider than Expected Q1 Miss
StreetInsider.com  May 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Flamel+Technologies+%28FLML%29+Lower+Following+Wider+than+Expected+Q1+Miss/7408310.html for the full story.




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Flamel_Technologies_S.A._(FLML)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki